A. Tehim

发表

Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats

Z. Xi, Xia Li, E. Gardner, 2009, Neuropharmacology.

1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands.

N. Maclean, A. Slassi, M. Isaac, 2002, Bioorganic & medicinal chemistry letters.

N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: human dopamine D4 ligands with high affinity for the 5-HT2A receptor.

K. Jarvie, J. Arora, A. Tehim, 2005, Bioorganic & medicinal chemistry letters.

Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats

A. Terry, P. Callahan, A. Tehim, 2014, Psychopharmacology.

A convenient synthesis of dihydropyranoxanthones

V. K. Ahluwalia, R. S. Jolly, A. Tehim, 1983 .

Total Synthesis of (-)-Tetrahydrolipstatin

S. Hanessian, A. Tehim, Ping Chen, 1993 .

Synthetic approaches to 4-spiro-2-hydroxytetronic acids

D. Witiak, A. Tehim, 1987 .

Synthesis of carboxy-2,2-dimethylchromans and chromenes

V. K. Ahluwalia, A. Tehim, 1983 .

No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery

M. Kam, G. Groeneveld, J. Hay, 2017, European journal of pain.

Structural features associated with reactive metabolite formation in clozapine analogues.

J. Uetrecht, N. Zahid, J. Fu, 1997, Chemico-biological interactions.

RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

D. Bertrand, L. Santarelli, W. Rowe, 2011, Journal of Pharmacology and Experimental Therapeutics.

Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat.

R. Riopelle, F. Porreca, M. Ossipov, 1999, The Journal of pharmacology and experimental therapeutics.

Phosphodiesterase inhibitors for cognitive enhancement.

M. De Vivo, G. Rose, A. Tehim, 2005, Current pharmaceutical design.

Synthesis of some 1,3,6-trioxygenated isopentenylated xanthones: Constitution of garcinone A

V. K. Ahluwalia, A. Tehim, 1984 .

N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists.

K. Jarvie, Nancy Barriault, J. Arora, 2004, Bioorganic & medicinal chemistry letters.

A remarkably facile and stereochemically controlled fragmentation reaction in the hygrolide group of macrolide antibiotics

S. Hanessian, Q. Meng, K. Granberg, 1996 .

Original Investigation

A. Terry, P. Callahan, A. Tehim, 2022 .

Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-Bioavailable 5-HT1D agonists

N. Maclean, L. Edwards, M. Isaac, 2003 .

No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery

G. Groeneveld, J. Hay, P. Okkerse, 2017, European journal of pain.

3-(2-pyrrolidin-1-ylethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity human 5-HT(1B/1D) ligands.

N. Maclean, A. Slassi, L. Edwards, 2004, Bioorganic & medicinal chemistry letters.

(R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands.

N. Maclean, A. Slassi, L. Edwards, 2003, Bioorganic & medicinal chemistry letters.

RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

D. Bertrand, L. Santarelli, W. Rowe, 2011, Journal of Pharmacology and Experimental Therapeutics.

RG3487, a Novel Nicotinic (cid:1) 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

G. Tombaugh, T. Wallace, J. Rodefer, 2010 .

RG3487, a Novel Nicotinic (cid:1) 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

G. Tombaugh, T. Wallace, J. Rodefer, 2010 .